Profilo
Dr Colas studied molecular biology at the University of Lyon and At the end of 1993, he joined the laboratory of Roger Brent, at the Department of Molecular Biology of Massachusetts General Hospital (Harvard Medical School, Boston, USA), where he contributed to the development of the peptide aptamer technology.
Dr Colas was recruited by the INSERM and came back to Lyon in 1998 to join Dr Rudkin's lab.
He pursued his work on peptide aptamer technologies.
In 2002, Dr Colas took a leave from the INSERM to become Scientific Director of Aptanomics.
Precedenti posizioni note di Pierre Colas
| Società | Posizione | Fine |
|---|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Direttore Tecnico/Scientifico/R&S | 24/01/2008 |
Formazione di Pierre Colas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Ecole Centrale Lyon
Ecole Centrale Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Normale Supérieure de Lyon
École Normale Supérieure de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















